It is the first injectable bone void filler in the U.S. to incorporate magnesium, and it isdesigned to treat insufficiency and microfractures, according to a Jan. 25 news release. Magnesium aids the bone’s absorption and regulation of calcium. Mg Osteoinject is resorbable and can assimilate back into the body during the healing process.
The injectable bone void filler is being distributed to healthcare facilities in the U.S., according to the release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
